MediWound Statistics
Total Valuation
MediWound has a market cap or net worth of $180.52 million. The enterprise value is $158.20 million.
Important Dates
The next confirmed earnings date is Tuesday, November 26, 2024, before market open.
Earnings Date | Nov 26, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
MediWound has 10.79 million shares outstanding. The number of shares has increased by 28.90% in one year.
Current Share Class | 10.79M |
Shares Outstanding | 10.79M |
Shares Change (YoY) | +28.90% |
Shares Change (QoQ) | +0.49% |
Owned by Insiders (%) | 1.93% |
Owned by Institutions (%) | 29.09% |
Float | 5.78M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 7.70 |
Forward PS | 6.40 |
PB Ratio | 8.72 |
P/TBV Ratio | 10.21 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 7.85 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 0.36.
Current Ratio | 1.65 |
Quick Ratio | 1.51 |
Debt / Equity | 0.36 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -1.35 |
Financial Efficiency
Return on equity (ROE) is -75.66% and return on invested capital (ROIC) is -32.07%.
Return on Equity (ROE) | -75.66% |
Return on Assets (ROA) | -15.77% |
Return on Capital (ROIC) | -32.07% |
Revenue Per Employee | $201,410 |
Profits Per Employee | -$199,730 |
Employee Count | 100 |
Asset Turnover | 0.33 |
Inventory Turnover | 5.53 |
Taxes
In the past 12 months, MediWound has paid $190,000 in taxes.
Income Tax | 190,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +101.44% in the last 52 weeks. The beta is 0.84, so MediWound's price volatility has been lower than the market average.
Beta (5Y) | 0.84 |
52-Week Price Change | +101.44% |
50-Day Moving Average | 17.26 |
200-Day Moving Average | 16.84 |
Relative Strength Index (RSI) | 47.62 |
Average Volume (20 Days) | 45,089 |
Short Selling Information
Short Interest | 593,041 |
Short Previous Month | 594,343 |
Short % of Shares Out | 6.43% |
Short % of Float | n/a |
Short Ratio (days to cover) | 18.59 |
Income Statement
In the last 12 months, MediWound had revenue of $20.14 million and -$19.97 million in losses. Loss per share was -$2.16.
Revenue | 20.14M |
Gross Profit | 2.67M |
Operating Income | -15.35M |
Pretax Income | -12.55M |
Net Income | -19.97M |
EBITDA | -14.50M |
EBIT | -15.35M |
Loss Per Share | -$2.16 |
Full Income Statement Balance Sheet
The company has $29.22 million in cash and $6.36 million in debt, giving a net cash position of $22.86 million or $2.12 per share.
Cash & Cash Equivalents | 29.22M |
Total Debt | 6.36M |
Net Cash | 22.86M |
Net Cash Per Share | $2.12 |
Equity (Book Value) | 17.87M |
Book Value Per Share | 1.92 |
Working Capital | 14.70M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$14.10 million and capital expenditures -$8.17 million, giving a free cash flow of -$22.27 million.
Operating Cash Flow | -14.10M |
Capital Expenditures | -8.17M |
Free Cash Flow | -22.27M |
FCF Per Share | -$2.06 |
Full Cash Flow Statement Margins
Gross margin is 13.25%, with operating and profit margins of -76.20% and -99.17%.
Gross Margin | 13.25% |
Operating Margin | -76.20% |
Pretax Margin | -98.22% |
Profit Margin | -99.17% |
EBITDA Margin | -72.01% |
EBIT Margin | -76.20% |
FCF Margin | -110.54% |
Dividends & Yields
MediWound does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -28.90% |
Shareholder Yield | -28.90% |
Earnings Yield | -11.03% |
FCF Yield | -12.30% |
Analyst Forecast
The average price target for MediWound is $28.00, which is 67.36% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $28.00 |
Price Target Difference | 67.36% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | 46.44% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on December 20, 2022. It was a reverse split with a ratio of 0.1428571:1.
Last Split Date | Dec 20, 2022 |
Split Type | Reverse |
Split Ratio | 0.1428571:1 |
Scores
MediWound has an Altman Z-Score of -3.18 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -3.18 |
Piotroski F-Score | 1 |